Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients
YOVINE, A, RIOFRIO, M, CVITKOVIC, E, MISSET, J. L, BLAY, J. Y, BRAIN, E, ALEXANDRE, J, KAHATT, C, TAAMMA, A, JIMENO, J, MARTIN, C, SALHI, Y
Published in Journal of clinical oncology (01.03.2004)
Published in Journal of clinical oncology (01.03.2004)
Get full text
Journal Article
Phase II Study of Oxaliplatin, Fluorouracil, and Folinic Acid in Locally Advanced or Metastatic Gastric Cancer Patients
LOUVET, C, ANDRE, T, ROUGIER, P, CVITKOVIC, E, DE GRAMONT, A, TIGAUD, J. M, GAMELIN, E, DOUILLARD, J. Y, BRUNET, R, FRANCOIS, E, JACOB, J. H, LEVOIR, D, TAAMMA, A
Published in Journal of clinical oncology (01.12.2002)
Published in Journal of clinical oncology (01.12.2002)
Get full text
Journal Article
Ecteinascidin-743: A Marine-Derived Compound in Advanced, Pretreated Sarcoma Patients—Preliminary Evidence of Activity
DELALOGE, S, YOVINE, A, MARTY, M, CVITKOVIC, E, TAAMMA, A, RIOFRIO, M, BRAIN, E, RAYMOND, E, COTTU, P, GOLDWASSER, F, JIMENO, J, MISSET, J. L
Published in Journal of clinical oncology (01.03.2001)
Published in Journal of clinical oncology (01.03.2001)
Get full text
Journal Article
A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer
ZELEK, L, YOVINE, A, BRAIN, E, TURPIN, F, TAAMMA, A, RIOFRIO, M, SPIELMANN, M, JIMENO, J, MISSET, J. L
Published in British journal of cancer (05.06.2006)
Published in British journal of cancer (05.06.2006)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors
TAAMMA, A, MISSET, J. L, RIOFRIO, M, GUZMAN, C, BRAIN, E, LOPEZ LAZARO, L, ROSING, H, JIMENO, J. M, CVITKOVIC, E
Published in Journal of clinical oncology (01.03.2001)
Published in Journal of clinical oncology (01.03.2001)
Get full text
Journal Article
Pharmacokinetics and Pharmacodynamics of the Novel Marine-derived Anticancer Agent Ecteinascidin 743 in a Phase I Dose-finding Study
VAN KESTEREN, Charlotte, CVITKOVIC, Esteban, HILLEBRAND, Michael J. X, ROSING, Hilde, BEIJNEN, Jos H, TAAMMA, Adelkrim, LOPEZ-LAZARO, Luis, JIMENO, Jose M, GUZMAN, Cecilia, MATHOT, Ron A. A, SCHELLENS, Jan H. M, MISSET, Jean-Louis, BRAIN, Etienne
Published in Clinical cancer research (01.12.2000)
Get full text
Published in Clinical cancer research (01.12.2000)
Journal Article
Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type
HASBINI, A, MAHJOUBI, R, RAYMOND, E, FANDI, A, CHOUAKI, N, TAAMMA, A, LIANES, P, CORTES-FUNES, H, ALONSO, S, ARMAND, J. P, CVITKOVIC, E
Published in Annals of oncology (01.04.1999)
Published in Annals of oncology (01.04.1999)
Get full text
Journal Article
A comparison of limited sampling strategies for prediction of Ecteinascidin 743 clearance when administered as a 24-h infusion
VAN KESTEREN, Charlotte, MATHOT, R. A. A, HILLEBRAND, M. J. X, ROSING, H, BEIJNEN, J. H, LOPEZ-LAZARO, L, CVITKOVIC, E, TAAMMA, A, JIMENO, J. M, GUZMAN, C, SCHELLENS, J. H. M, MISSET, J. L, BRAIN, E
Published in Cancer chemotherapy and pharmacology (01.12.2001)
Published in Cancer chemotherapy and pharmacology (01.12.2001)
Get full text
Journal Article
Schedule-dependent paclitaxel tolerance/activity: data from a 7 day infusion phase I study with pharmacokinetics in paclitaxel refractory ovarian cancer
Soulié, P, Trandafir, L, Taamma, A, Lokiec, F, Brain, E, Delord, J P, Mita, A, Vannetzel, J M, Cvitkovic, E, Misset, J L
Published in Anti-cancer drugs (01.09.1997)
Published in Anti-cancer drugs (01.09.1997)
Get more information
Journal Article
First-in-human phase I safety, pharmacokinetic (PK), and pharmacodynamic (PD) analysis of the oral MEK-inhibitor AS703026 (two regimens [R]) in patients (pts) with advanced solid tumors
Delord, J., Houede, N., Awada, A., Taamma, A., Faivre, S. J., Besse-Hammer, T., Italiano, A., Vignaud, C., Donica, M., Raymond, E.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Long-Term Disease-Free Survivors in Metastatic Undifferentiated Carcinoma of Nasopharyngeal Type
FANDI, A, BACHOUCHI, M, AZLI, N, TAAMMA, A, BOUSSEN, H, WIBAULT, P, ESCHWEGE, F, ARMAND, J.-P, SIMON, J, CVITKOVIC, E
Published in Journal of clinical oncology (01.03.2000)
Published in Journal of clinical oncology (01.03.2000)
Get full text
Journal Article
Conference Proceeding
Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival
Published in International journal of radiation oncology, biology, physics
(01.06.1996)
Get full text
Journal Article
Phase II trial of chemotherapy with 5‐fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type
Taamma, Abdelkrim, Fandi, Abdelrahim, Azli, Nacer, Wibault, Pierre, Chouaki, Nadia, Hasbini, Ali, Couteau, Corinne, Armand, Jean‐Pierre, Cvitkovic, Esteban
Published in Cancer (01.10.1999)
Published in Cancer (01.10.1999)
Get full text
Journal Article
Pilot study of the paclitaxel, oxaliplatin, and cisplatin combination in patients with advanced/recurrent ovarian cancer
Delaloge, S, Laadem, A, Taamma, A, Chouaki, N, Cvitkovic, E, Pautier, P, Misset, J L, Lhommé, C
Published in American journal of clinical oncology (01.12.2000)
Published in American journal of clinical oncology (01.12.2000)
Get more information
Journal Article
Ecteinascidin (ET-743) in heavily pretreated refractory sarcomas: Preliminary evidence of activity
Delaloge, S., Riofrio, M., Brain, E., Cottu, P., Taamma, A., Marty, M., Guzman, C., Misset, J.L., Cvitkovic, E.
Published in European journal of cancer (1990) (01.09.1999)
Published in European journal of cancer (1990) (01.09.1999)
Get full text
Journal Article
Phase I clinical study of ecteinascidin-743 (ET-743) as a 24 hours continuous intravenous infusion (CI) in patients (pts) with solid tumors (st): A progress report
Taamma, A., Cvilkovic, E., Jimeno, J., Gasparetto, M., Meeley, K., Vega, E., Cameron, L., Misset, J.L.
Published in European journal of cancer (1990) (01.09.1997)
Published in European journal of cancer (1990) (01.09.1997)
Get full text
Journal Article
Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngealtype
Hasbini, A., Mahjoubi, R., Fandi, A., Chouaki, N., Taamma, A., Lianes, P., Cortès-Funes, H., Alonso, S., Armand, J. P., Cvitkovic, E., Raymond, E.
Published in Annals of oncology (01.04.1999)
Published in Annals of oncology (01.04.1999)
Get full text
Journal Article
Ecteinascidin (ET-743) pharmacokinetics (PK)-overview of phase i and advanced phase II results
Lopez-Lazaro, L., can Kesteren, C., Hoekman, K., Twelves, C., Bowman, A., Taamma, A., Le Cesne, A., Demetri, G., Fumoleau, P., Aamdal, S., Paz-Ares, L., Poveda, A., Rivera, F., Sessa, C., Rosing, H., Lopez-Martin, K., Reid, J., Supko, J., Beijnen, J.
Published in European journal of cancer (1990) (01.04.2001)
Published in European journal of cancer (1990) (01.04.2001)
Get full text
Journal Article
Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma type
Fandi, Abderrahim, Taamma, Abdelkrim, Azli, Nacer, Bachouchi, Mounir, Yanes, Bashar, Armand, Jean Pierre, Cvitkovic, Esteban
Published in Head & neck (01.01.1997)
Published in Head & neck (01.01.1997)
Get full text
Journal Article